Legal

Disclaimer

Effective: July 22, 2026 · Governing Law: State of Georgia, USA

Read Before Using This Platform

BiotechSign provides data and research tools for informational purposes only. Nothing on this platform constitutes investment, financial, medical, or regulatory advice. All investment decisions carry the risk of total loss. By using this platform, you accept all terms of this disclaimer in full.

1. Informational and Educational Purposes Only

ALL DATA, CONTENT, SCORES, SIGNALS, PDUFA CALENDARS, CLINICAL TRIAL SUMMARIES, FDA DECISION ANALYSES, AND ANY OTHER INFORMATION PROVIDED BY BIOTECHSIGN IS FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. NOTHING ON THIS PLATFORM — INCLUDING ANY BIOTECH SCORE, APPROVAL PROBABILITY, CATALYST ALERT, OR ANALYST-STYLE SUMMARY — CONSTITUTES INVESTMENT ADVICE, FINANCIAL ADVICE, TRADING ADVICE, TAX ADVICE, LEGAL ADVICE, MEDICAL ADVICE, REGULATORY ADVICE, OR ANY OTHER FORM OF PROFESSIONAL OR REGULATED GUIDANCE.

2. Not a Registered Investment Advisor or Broker-Dealer

Guerilla Finance Inc. is NOT registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser under the Investment Advisers Act of 1940, is NOT registered as a broker-dealer under the Securities Exchange Act of 1934, and is NOT a member of the Financial Industry Regulatory Authority (FINRA) or any other self-regulatory organization. BiotechSign does not hold, manage, or trade assets on behalf of any user. Nothing on this platform should be construed as a solicitation or offer to buy or sell any security.

3. No Advisory, Fiduciary, or Client Relationship

Your use of BiotechSign does not create any advisory, fiduciary, broker-dealer, investment manager, or client relationship between you and Guerilla Finance Inc. of any kind. We do not act as your financial adviser, investment adviser, or in any fiduciary capacity. We owe you no fiduciary duty, duty of loyalty, duty of care, or any other professional duty in connection with your use of this platform or any investment, trading, or financial decision you make. The existence of a subscription or paid plan does not alter this — it is a license for data access, not an advisory relationship.

4. No Buy, Sell, or Hold Recommendations

BiotechSign does not recommend that any security be purchased, sold, held, or avoided. Biotech scores, approval probability estimates, catalyst countdowns, PDUFA date alerts, clinical stage assessments, and any other signals or indicators are aggregations of publicly available information processed through proprietary algorithms. They are not personalized investment recommendations and should not be interpreted as such. A high score, bullish signal, or upcoming catalyst alert is not a recommendation to buy the associated security.

5. Extreme Biotech and Pharmaceutical Investment Risk

Critical Risk Warning

Biotech and pharmaceutical investing carries extreme, binary risk unlike most other investment categories. You can lose your entire investment in a single trading session based on a single regulatory decision.

You expressly acknowledge and accept all of the following risks associated with biotech investing:

  • Biotech investments are subject to extreme volatility and may lose 50–100% of their value based on a single FDA decision;
  • Complete and total loss of capital is a known, documented, and common outcome in biotech investing;
  • FDA approval decisions are made by a regulatory agency beyond the control of any company, investor, or data platform;
  • Clinical trial results are inherently uncertain; positive Phase 2 results do not predict Phase 3 success;
  • Market expectations embedded in stock prices may not align with actual FDA outcomes;
  • Biotech stocks are subject to manipulation, short squeezes, and extreme speculative behavior;
  • Small-cap and micro-cap biotech companies carry additional risks including limited liquidity and potential for fraud;
  • You are solely responsible for independently evaluating all risks before investing in any biotech or pharmaceutical security.

6. FDA Decision Risk and Unpredictability

FDA regulatory decisions are the product of a complex, multi-factor process that cannot be reliably predicted by any data platform, analyst, or algorithm. Specifically:

  • PDUFA dates (FDA action dates) are target dates only — the FDA may take action earlier or later, or issue a Complete Response Letter at any time;
  • Advisory committee (AdCom) votes are advisory only and do not determine FDA approval decisions;
  • Approval probability scores on this platform are historical statistical estimates and are not predictions of specific FDA decisions;
  • The FDA may impose unexpected post-marketing requirements, label restrictions, REMS programs, or accelerated approval conditions;
  • Fast Track, Breakthrough Therapy, and other designations accelerate FDA review but do not guarantee approval;
  • Drug approvals may be delayed, denied, or withdrawn at any stage of review for clinical, manufacturing, labeling, or safety reasons;
  • Any apparent PDUFA date, approval timeline, or regulatory milestone on this platform may be inaccurate, outdated, or subject to change without notice.

7. Data Accuracy, Completeness, and Timeliness

BiotechSign aggregates data from SEC EDGAR, FDA databases, ClinicalTrials.gov, and other public sources. Despite our best efforts, we cannot guarantee the accuracy, completeness, or timeliness of any data on this platform. Specifically:

  • PDUFA dates and regulatory timelines may change without notice and may not be immediately reflected on this platform;
  • Clinical trial statuses, enrollment figures, primary endpoints, and results may be updated by sponsors and may not be reflected in real-time;
  • SEC filing data is subject to reporting delays, amendments, and corrections that may not be immediately reflected;
  • Data sourced from third-party providers may contain errors, omissions, or formatting changes beyond our control;
  • Historical clinical trial data may be incomplete, particularly for older studies or international trials;
  • Drug name changes, company mergers, and NDA/BLA numbering changes may cause data matching errors;
  • Platform downtime, data pipeline failures, or API outages may cause data to be temporarily unavailable or stale.

Always verify all regulatory information from official primary sources: FDA.gov, ClinicalTrials.gov, the SEC EDGAR database, and official company investor relations communications.

8. Algorithmic and Model Limitations

BiotechSign's scores, probabilities, and signals are produced by proprietary algorithms and machine learning models. These models are trained on historical data and cannot predict future FDA decisions, clinical trial outcomes, or market prices. Model outputs may be biased, incorrect, or based on outdated training data. Algorithmic scores do not account for all factors that may affect a drug's regulatory success or a company's stock price. You should treat algorithmic outputs as one data point among many, not as authoritative assessments.

9. AI-Generated and AI-Augmented Content

Some content on BiotechSign — including summaries, analyses, and descriptive text — may be generated or augmented by artificial intelligence systems. AI-generated content does not constitute investment, financial, medical, or regulatory advice and may contain factual errors, omissions, outdated information, or mischaracterizations. AI systems can and do make mistakes. Always verify information from primary sources including official SEC filings, FDA.gov, ClinicalTrials.gov, and official company communications before making any decision based on it.

10. Third-Party Data Sources

BiotechSign integrates data from third-party providers. Guerilla Finance Inc. is not responsible for the accuracy, availability, or reliability of any third-party data, including:

  • SEC EDGAR (SEC.gov) — delays in filing indexing, EDGAR API outages, or filing errors are not within our control;
  • FDA.gov — database updates, PDUFA date revisions, or label changes may not be immediately available;
  • ClinicalTrials.gov — trial registration accuracy and update frequency are the responsibility of trial sponsors;
  • DilutionWatch, StonkWhisper, and other Guerilla Finance platforms — cross-platform data integrations are provided as-is;
  • Any market data provider, financial data service, or news aggregator whose data appears on this platform.

Guerilla Finance Inc. expressly disclaims all responsibility for errors, omissions, or service disruptions at any third-party data provider. Use of third-party data on this platform does not constitute endorsement of those providers or their data.

11. Past Performance and Historical Data

Historical FDA approval rates, past PDUFA outcomes, prior clinical trial success statistics, and historical biotech stock performance presented on this platform are for illustrative and research purposes only. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. Historical approval rates for a drug class, indication, or sponsor do not predict the probability of approval for any specific drug under review. Historical patterns in biotech stock prices do not predict future price movements.

12. No Predictions or Guarantees

Nothing on BiotechSign constitutes a prediction, projection, or guarantee of any FDA decision, clinical trial outcome, regulatory timeline, or security price. Approval probability scores are statistical estimates based on historical patterns and are not predictions. We make no warranty that any drug, therapy, or device will receive regulatory approval. We make no warranty that any biotech stock will increase in value. Any apparent prediction-like language is for illustrative purposes only and not a guarantee of any outcome.

13. Not Medical, Clinical, or Regulatory Advice

Nothing on BiotechSign constitutes medical advice, clinical guidance, health information intended for patient use, or regulatory strategy advice. Clinical trial data, drug mechanism summaries, safety profiles, and efficacy data are presented for investor research purposes only. This platform is not intended for healthcare providers making clinical decisions, patients making treatment decisions, or companies making regulatory strategy decisions. Do not rely on BiotechSign for any health, medical, or regulatory decision.

14. Not Tax or Legal Advice

Nothing on BiotechSign constitutes tax advice, legal advice, or estate planning advice. Investment decisions in biotech securities may have significant tax consequences including ordinary income treatment, capital gains treatment, or complex wash-sale considerations. You should consult a qualified tax professional and/or attorney before making investment decisions with tax implications.

15. Your Sole Responsibility

You are solely and exclusively responsible for all of the following:

  • All investment, trading, and financial decisions you make, regardless of any information you obtain from BiotechSign;
  • Conducting your own thorough independent research and due diligence, including reviewing primary source documents such as SEC filings, FDA documents, and official company communications;
  • Understanding the extreme risks associated with biotech investing, including the documented risk of total loss of capital;
  • Ensuring your investments are appropriate for your personal financial situation, risk tolerance, investment objectives, and time horizon;
  • Compliance with all applicable securities laws, tax laws, and regulations governing your investing and trading activities;
  • Verifying all PDUFA dates, clinical trial statuses, and FDA decisions from official government sources before making any investment decision;
  • Any losses, damages, or liabilities that result from your investment or trading decisions;
  • Seeking qualified professional advice (financial, legal, tax, medical) as appropriate for your situation.

16. No Liability for Investment Losses or Damages

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, GUERILLA FINANCE INC., ITS OWNERS, OFFICERS, EMPLOYEES, CONTRACTORS, AFFILIATES, DATA PROVIDERS, AND AGENTS SHALL NOT BE LIABLE TO YOU OR ANY THIRD PARTY FOR ANY TRADING LOSSES, INVESTMENT LOSSES, LOSS OF CAPITAL, LOST PROFITS, LOST REVENUE, MISSED OPPORTUNITIES, OR ANY OTHER DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, OR EXEMPLARY DAMAGES ARISING FROM OR RELATED TO: (A) YOUR USE OF OR RELIANCE ON ANY DATA, SCORE, SIGNAL, OR CONTENT ON BIOTECHSIGN; (B) ANY INVESTMENT OR TRADING DECISION YOU MAKE BASED ON PLATFORM DATA; (C) ANY FDA DECISION, CLINICAL TRIAL OUTCOME, OR REGULATORY EVENT; (D) ANY INACCURACY, ERROR, OMISSION, OR DELAY IN PLATFORM DATA; (E) ANY PLATFORM OUTAGE OR UNAVAILABILITY; (F) UNAUTHORIZED ACCESS TO YOUR DATA. THIS LIMITATION APPLIES REGARDLESS OF THE LEGAL THEORY ASSERTED AND EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. OUR TOTAL AGGREGATE LIABILITY FOR ANY CLAIM SHALL NOT EXCEED FIFTY U.S. DOLLARS (.00).

17. Your Indemnification Obligation

By using BiotechSign, you agree to indemnify, defend, and hold harmless Guerilla Finance Inc. and its owners, officers, employees, contractors, and agents from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising from: (a) any investment or trading decision you make based on any information from BiotechSign; (b) your violation of these terms or applicable law; (c) your misuse of the platform; or (d) any claim by a third party arising from your use of BiotechSign data.

18. Consult Qualified Professionals

Before making any investment decision — particularly in the biotech and pharmaceutical sector — you should consult with a licensed, qualified financial advisor, registered investment adviser, or broker-dealer who can provide personalized investment advice tailored to your specific financial situation, risk tolerance, investment objectives, and time horizon. You should also consult qualified medical and regulatory professionals regarding clinical and regulatory matters. BiotechSign is a research tool that supplements, but does not replace, professional advice.

19. Geographic Scope and Regulatory Compliance

BiotechSign is operated from the United States and is primarily intended for U.S.-based investors. Use of BiotechSign from outside the United States may not be appropriate and may be restricted in certain jurisdictions. Users accessing this platform from outside the United States are solely responsible for determining whether such use complies with applicable local laws, regulations, and restrictions governing the receipt and use of financial research and data services. Guerilla Finance Inc. makes no representation that BiotechSign or its content is legally permissible in any jurisdiction outside the United States.

20. Forward-Looking Information

This platform may present forward-looking estimates, timelines, approval probability assessments, and market projections. Such forward-looking information is inherently speculative and subject to significant uncertainty. Actual outcomes may differ materially from any estimate, projection, or forward-looking statement on this platform due to factors including regulatory agency decisions, new safety or efficacy data, changes in competitive landscape, market conditions, macroeconomic factors, and geopolitical events. Forward-looking information should not be relied upon as fact.

21. Potential Conflicts of Interest

Guerilla Finance Inc. and its principals may from time to time hold long or short positions in securities of companies featured on BiotechSign. The existence or non-existence of such positions is not disclosed on a real-time basis. Additionally, biotech scores and signal prioritization algorithms may inadvertently favor or disfavor certain securities or sectors due to data availability, algorithm design, or coverage decisions. You should be aware of these potential conflicts when interpreting platform data.

22. User Acknowledgment and Assumption of Risk

BY ACCESSING OR USING BIOTECHSIGN, YOU EXPRESSLY ACKNOWLEDGE THAT: (A) YOU HAVE READ AND UNDERSTAND THIS DISCLAIMER IN ITS ENTIRETY; (B) BIOTECHSIGN PROVIDES DATA AND RESEARCH TOOLS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT PROVIDE INVESTMENT, FINANCIAL, MEDICAL, OR REGULATORY ADVICE; (C) ALL INVESTMENT DECISIONS ARE MADE SOLELY AT YOUR OWN RISK AND JUDGMENT; (D) YOU ACCEPT FULL AND SOLE RESPONSIBILITY FOR ANY LOSSES OR DAMAGES ARISING FROM YOUR USE OF THIS PLATFORM OR ANY INVESTMENT DECISION YOU MAKE; (E) YOU WAIVE ANY CLAIM AGAINST GUERILLA FINANCE INC. ARISING FROM YOUR RELIANCE ON ANY PLATFORM DATA OR CONTENT. THIS DISCLAIMER SUPPLEMENTS AND IS IN ADDITION TO THE BIOTECHSIGN TERMS OF SERVICE. IN THE EVENT OF ANY CONFLICT, THE TERMS OF SERVICE GOVERN.

This disclaimer is provided in addition to and supplements the BiotechSign Terms of Service. In the event of any conflict, the Terms of Service govern.

Questions? Contact us at admin@dilutionwatch.com

© 2026 Guerilla Finance Inc. BiotechSign is a product of Guerilla Finance Inc.